Forsyth Douglas
FORSYTH DOUGLAS, DIR, reported an open-market or private purchase at Inhibrx Biosciences, Inc. involving 2500.000000 shares for an estimated $286617.25. Reported holdings after the transaction were 227064.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 08, 2026
- Filing date
- Sep 08, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 224,564 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
INBX price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001240801-26-000004 Common Stock
- Transaction date
- Sep 08, 2026 Filed Sep 08, 2026, 08:26 PM · 0d delay
- Shares
- 2,500 sh $114.65 per share
- Estimated value
- $286k Computed from shares × price
- Holdings after
- 227,064 sh Indirect · By the Forsyth Family Trust Dated July 20, 2001
Filing signal explanations
Badges describe filing facts only — not predictions.
+36 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - director_buy+6 points
is_director = true
Director open-market purchase. - cluster_buy+14 points
cluster-buy signal matched
Multiple insiders bought within the configured window. - timely_filing+4 points
reporting_delay_days = 0
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The shares were purchased in multiple transactions at prices ranging from $114.36 to $114.689 inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby un…
- F2
The reporting person is a trustee of the Forsyth Family Trust Dated July 20, 2001 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Forsyth Family Trust D…
0 other transactions
0 recent txs